
Velakast Tablet
Marketer
Aprazer Healthcare Pvt Ltd
Salt Composition
Sofosbuvir (400mg) + Velpatasvir (100mg)
Overview Velakast Tablet
Velakast tablets contain a dual antiviral formulation, prescribed for managing chronic hepatitis C (HCV). This medication combats the HCV virus to achieve infection resolution. Adhere strictly to the prescribed dosage and regimen; it may be taken with or without food, but consistently at the same time each day. Exceeding the recommended dose is unsafe. Disclose any pre-existing conditions, particularly liver or kidney ailments, to your physician before commencing treatment. Concurrent alcohol consumption is detrimental; limit or abstain entirely. Complete the full course for optimal therapeutic outcomes. Common adverse reactions include tiredness, anemia, nausea, headache, sleep disturbances, and bowel irregularities. Maintain adequate hydration and a nutritious diet to mitigate these effects. Always inform your doctor about all other medications or supplements you are using prior to starting Velakast.
Uses of Velakast Tablet
Managing persistent Hepatitis C virus (HCV) infection
Major Benefits of Velakast Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Velakast Tablets can be consumed with or without food, however, consistent timing is recommended for optimal results.
Common Side effects of Velakast Tablet:
- Headache
- Tiredness
- Diarrhea
How to use Velakast Tablet:
Administer this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid crushing, chewing, or breaking it. Velakast Tablets can be consumed with or without food, though consistent timing is recommended.
How Velakast Tablet works:
Velakast tablets contain Sofosbuvir and Velpatasvir, two antiviral medications that collaboratively reduce the hepatitis C viral load, ultimately eliminating the virus from the bloodstream.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Velakast Tablet lacks established safety data. Physician consultation is advised.
PregnancyCONSULT YOUR DOCTOR
Data on Velakast Tablet use in pregnancy is lacking. Seek your physician's advice.
Breast feedingSAFE IF PRESCRIBED
Breastfeeding mothers can likely use Velakast Tablet without significant concern. Available human data indicates minimal risk to the infant.
DrivingUNSAFE
Driving ability may be impaired by Velakast Tablet side effects. Concurrent use of Velakast Tablet with other hepatitis C medications can lead to dizziness and blurred vision, potentially impacting driving safety.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using Velakast Tablet, as dose modification may be necessary. Consult your physician for guidance. Data regarding Velakast Tablet use in such patients is limited. Dosage alteration isn't advised for individuals with mild to moderate kidney disease.
LiverSAFE IF PRESCRIBED
Patients with liver impairment can safely use Velakast tablets without requiring a dosage change. However, kidney disease should be disclosed to your physician, as some patients may need routine liver function monitoring while on this medication.
What if you forget to take Velakast Tablet :
Should you forget a Velakast Tablet dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Velakast Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
